INNOHEP 10 000 IU anti-Xa/0.5 ml, solution for injection in a pre-filled syringe 2 syringes of 0.5 ml
Active ingredients: Tinzaparin sodium
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 syringes of 0.5 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- INNOHEP 10 000 UI anti-Xa/0,5 ml, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 2 seringue(s) préremplie(s) en verre de 0,5 ml avec aiguille(s) et dispositif de sécurité
- Marketing authorisation holder
- LABORATOIRES LEO
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Dec 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67167017CIP73397239CIP133400933972394Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TINZAPARINE SODIQUEsolution | 10 000 UI Anti-Xa · 0,5 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.